[1]
R. L. Pacheco, A. L. C. Martimbianco, C. de O. C. Latorraca, and R. Riera, “Why COVID-19 trials should be blinded (as any other one)”, Evidence, vol. 2, no. 1, pp. 25–27, Apr. 2020.